Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026

Core Viewpoint - Anika Therapeutics, Inc. will release its fourth quarter and year-end 2025 financial results on February 26, 2026, followed by a conference call to discuss the results and business highlights [1]. Group 1: Financial Results Announcement - The financial results will be issued before the market opens on February 26, 2026 [1]. - A conference call is scheduled for 8:30 a.m. ET on the same day to discuss the results [1]. Group 2: Conference Call Access - The conference call can be accessed via a toll-free domestic number (1-800-717-1738) or an international number (1-646-307-1865) with the conference ID number 89327 [2]. - A live audio webcast and presentation materials will be available on Anika's Investor Relations website [2]. - The call will be archived and accessible shortly after its conclusion on the same website [2]. Group 3: Company Overview - Anika Therapeutics, Inc. is a global joint preservation company focused on early intervention orthopedic care [3]. - The company specializes in hyaluronic acid and implant solutions, partnering with clinicians to provide minimally invasive products [3]. - Anika targets high opportunity areas within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, with products delivered in key care sites like ambulatory surgery centers [3]. - The company's global operations are headquartered outside of Boston, Massachusetts [3].